fasedienol
fasedienol: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | Phase 3 |
Clinical Trials (1)
US, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-4)
Frequently asked questions
Who is developing fasedienol?
fasedienol is being developed by Vistagen Therapeutics, Inc..
How many clinical trials involve fasedienol?
BioSniper tracks 1 clinical trial involving fasedienol.
Get deeper analysis on fasedienol
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis